{
  "id": 1542,
  "text": "# 13.3 Development group comments There was uniform agreement in the development group based on level 1 evidence (meta-analyses and phase III chemoradiotherapy trials) that combined chemoradiotherapy and brachytherapy is the method of choice for the management of stage T2b-T4a cervical cancer and also for stage T1b2/T2a2 with involved LNs on radiological staging (iN1).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: # 13.3 Development group comments There was uniform agreement in the development group based on level 1 evidence (meta-analyses and phase III chemoradiotherapy trials) that combined chemoradiotherapy and brachytherapy is the method of choice for the management of stage T2b-T4a cervical cancer and also for stage T1b2/T2a2 with involved LNs on radiological staging (iN1).\n\n<question>: ",
  "ChatGPT_response_0": "我赞同开发组的观点，根据一级证据（元分析和III期化疗放疗试验），对于T2b-T4a宫颈癌和具有放射学分期上涉及LN（iN1）的T1b2/T2a2期患者，联合化疗放疗和近距离放疗是首选方法，可以带来最佳的治疗效果。这种综合治疗方案可以有效控制病情，并提高患者的生存率和生存质量。因此，在实际临床实践中，这种治疗方法值得推荐和采用。",
  "query": "对于T2b-T4a宫颈癌和具有放射学分期上涉及LN（iN1）的T1b2/T2a2期患者，开发组意见一致，认为联合化疗放疗和近距离放疗是首选方法。您是否赞同这一观点？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 对于T2b-T4a宫颈癌和具有放射学分期上涉及LN（iN1）的T1b2/T2a2期患者，开发组意见一致，认为联合化疗放疗和近距离放疗是首选方法。您是否赞同这一观点？\n\n<reference text>: # 13.3 Development group comments There was uniform agreement in the development group based on level 1 evidence (meta-analyses and phase III chemoradiotherapy trials) that combined chemoradiotherapy and brachytherapy is the method of choice for the management of stage T2b-T4a cervical cancer and also for stage T1b2/T2a2 with involved LNs on radiological staging (iN1).\n\n<reply>: ",
  "response": "我赞同开发组的观点，根据一级证据（元分析和III期化疗放疗试验），对于T2b-T4a宫颈癌和具有放射学分期上涉及LN（iN1）的T1b2/T2a2期患者，联合化疗放疗和近距离放疗是首选方法，可以带来最佳的治疗效果。这种综合治疗方案可以有效控制病情，并提高患者的生存率和生存质量。因此，在实际临床实践中，这种治疗方法值得推荐和采用。"
}